Home326030 • KRX
add
SK Biopharmaceuticals Co Ltd
Previous close
₩115,100.00
Day range
₩113,600.00 - ₩116,700.00
Year range
₩72,600.00 - ₩130,000.00
Market cap
9.02T KRW
Avg Volume
258.98K
P/E ratio
157.22
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 136.60B | 51.21% |
Operating expense | 100.73B | 6.87% |
Net income | 9.65B | 169.30% |
Net profit margin | 7.07 | 145.85% |
Earnings per share | — | — |
EBITDA | 23.62B | 449.19% |
Effective tax rate | 33.60% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 267.54B | -1.95% |
Total assets | 775.02B | 3.19% |
Total liabilities | 408.76B | -4.62% |
Total equity | 366.26B | — |
Shares outstanding | 78.31M | — |
Price to book | 26.68 | — |
Return on assets | 6.05% | — |
Return on capital | 8.63% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 9.65B | 169.30% |
Cash from operations | 22.46B | 657.34% |
Cash from investing | -13.24B | -109.10% |
Cash from financing | -25.99B | -235.27% |
Net change in cash | -18.83B | -111.42% |
Free cash flow | 3.62B | -73.39% |
About
Founded
1993
Website
